Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
high-activity human umbilical cord mesenchymal stem cell injection
- Development stage
- Unknown
- Lead developer
- Health-Biotech Pharmaceutical
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Injection
01
Overview
High-activity human umbilical cord mesenchymal stem cell injection is an investigational cell therapy developed by Health-Biotech Pharmaceutical (Health-biotech France). The product consists of mesenchymal stem cells (MSCs) derived from human umbilical cord tissue, which are specifically processed to maintain high biological activity. These cells are intended to treat Severe Lower Limb Ischemia (SLLI) by promoting angiogenesis, facilitating tissue repair, and providing immunomodulatory effects in ischemic environments. An Investigational New Drug (IND) application for this therapy was filed in France in June 2019, with clinical studies conducted at the Reims University Medical Center. It is currently in Phase 1 clinical development.
- Other names
- 高活性人脐带间充质干细胞注射液High-Activity Human Umbilical Cord Mesenchymal Stem Cell Injection
Beyond the preview
Go deeper on high-activity human umbilical cord mesenchymal stem cell injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on high-activity human umbilical cord mesenchymal stem cell injection.